ORCID as entered in ROS

Select Publications
2012, 'The public health implications of genetic research on addiction', in Genetic Research on Addiction Ethics the Law and Public Health, pp. 155 - 173, http://dx.doi.org/10.1017/CBO9781139058971.012
,2012, 'Chapter 13 Population Approaches to Alcohol, Tobacco and Drugs Effectiveness, Ethics and Interplay with Addiction Neuroscience', in Addiction Neuroethics, Elsevier, pp. 247 - 260, http://dx.doi.org/10.1016/b978-0-12-385973-0.00013-2
,2012, 'Chapter 5 Emerging Neurobiological Treatments of Addiction Ethical and Public Policy Considerations', in Addiction Neuroethics, Elsevier, pp. 95 - 113, http://dx.doi.org/10.1016/b978-0-12-385973-0.00005-3
,2012, 'Chapter 6 Technical, Ethical and Social Issues in the Bioprediction of Addiction Liability and Treatment Response', in Addiction Neuroethics, Elsevier, pp. 115 - 135, http://dx.doi.org/10.1016/b978-0-12-385973-0.00006-5
,2012, 'Substance-related disorders', in Meadows G; Farhall J; Fossey E; Grigg M; McDermott F; Singh B (ed.), Mental Health In Australia, Oxford University Press, South Melbourne, Vic., pp. 694 - 707, http://trove.nla.gov.au/work/7778919?selectedversion=NBD48767811
,2011, 'Challenges in Reducing the Disease Burden of Tobacco Smoking', in Substance Abuse Disorders, pp. 274 - 279, http://dx.doi.org/10.1002/9780470975084.ch22
,2011, 'Emerging Neurobiological Treatments of Addiction: Ethical and Public Policy Considerations', in Addiction Neuroethics the Ethics of Addiction Neuroscience Research and Treatment, pp. 95 - 113, http://dx.doi.org/10.1016/B978-0-12-385973-0.00005-3
,2011, 'Introduction: What is Addiction Neuroethics and Why Does it Matter?', in Addiction Neuroethics the Ethics of Addiction Neuroscience Research and Treatment, pp. xvii - xxv, http://dx.doi.org/10.1016/B978-0-12-385973-0.00019-3
,2011, 'Population Approaches to Alcohol, Tobacco and Drugs: Effectiveness, Ethics and Interplay with Addiction Neuroscience', in Addiction Neuroethics the Ethics of Addiction Neuroscience Research and Treatment, pp. 247 - 260, http://dx.doi.org/10.1016/B978-0-12-385973-0.00013-2
,2011, 'Technical, Ethical and Social Issues in the Bioprediction of Addiction Liability and Treatment Response', in Addiction Neuroethics the Ethics of Addiction Neuroscience Research and Treatment, pp. 115 - 135, http://dx.doi.org/10.1016/B978-0-12-385973-0.00006-5
,2011, 'Gateway Drug Use', in Encyclopedia of Adolescence, Springer New York, pp. 1116 - 1122, http://dx.doi.org/10.1007/978-1-4419-1695-2_79
,2010, 'A Cautious Case for Cannabis Depenalization', in Pot Politics Marijuana and the Costs of Prohibition, http://dx.doi.org/10.1093/acprof:oso/9780195188028.003.0005
,2010, 'Ethical Issues in Alcohol, other Drugs and Addiction-Related Research', in Addiction Research Methods, pp. 79 - 93, http://dx.doi.org/10.1002/9781444318852.ch6
,2008, 'Drug use and drug dependence', in Essential Psychiatry Fourth Edition, pp. 230 - 249, http://dx.doi.org/10.1017/CBO9780511544125.012
,2007, 'Ethical and policy issues in the translation of genetic and neuroscience research on addiction', in Translation of Addictions Science into Practice, pp. 439 - 457, http://dx.doi.org/10.1016/B978-008044927-2/50070-5
,2007, 'Drug Addiction, Society and Ethics', in Principles of Health Care Ethics Second Edition, pp. 639 - 645, http://dx.doi.org/10.1002/9780470510544.ch87
,2006, 'The adverse health and psychological consequences of cannabis dependence', in Cannabis Dependence Its Nature Consequences and Treatment, pp. 106 - 128, http://dx.doi.org/10.1017/CBO9780511544248.007
,2006, 'The policy implications of cannabis dependence', in Cannabis Dependence Its Nature Consequences and Treatment, pp. 315 - 340, http://dx.doi.org/10.1017/CBO9780511544248.016
,2005, 'Ethical considerations for drug abuse epidemiologic research', in Epidemiology of Drug Abuse, pp. 145 - 157, http://dx.doi.org/10.1007/0-387-24416-6_10
,2004, 'Is there a specific ‘cannabis psychosis’?', in Marijuana and Madness, Cambridge University Press, pp. 89 - 100, http://dx.doi.org/10.1017/cbo9780511543630.008
,2004, 'The association between cannabis use and depression: a review of the evidence', in Marijuana and Madness, Cambridge University Press, pp. 54 - 74, http://dx.doi.org/10.1017/cbo9780511543630.006
,2003, 'Methadone and opioid-related deaths', in Methadone Matters, CRC Press, pp. 155 - 165, http://dx.doi.org/10.1201/b14312-19
,2001, 'What is comorbidity and why does it matter?', in National Comorbidity Project, Commonwealth of Australia, Canberra, pp. 11 - 17
,2000, 'Alcohol-use disorders: who should be treated and how?', in Unmet Need in Psychiatric Disorders: Problems, Resources and Responses, Cambridge University Press, United Kingdom, pp. 290 - 301
,2000, 'Dependence', in Cannabis and cannabinoids: Pharmacology and therapeutic potential (German edition), Verlag Hans Huber, Bern, Germany, pp. 283 - 294
,1999, 'Assessing the health and psychological effects of cannabis use', in The Health Effects of Cannabis, Addiction Research Foundation, Division of the, Ontario, Canada, pp. 3 - 17
,1999, 'Comparing the heatlh and psychological risks of alcohol, cannabis, nicotine and opiate use', in The Health Effects of Cannabis, Addiction Research Foundation, Division of the, Ontario, Canada, pp. 477 - 506
,1999, 'Effects of cannabis on the cardiovascular and gastrointestinal systems', in The Health Effects of Cannabis, Addiction Research Foundation, Division of the, Ontario, Canada, pp. 437 - 458
,1999, 'Epidemiology of cannabis use and its consequences', in The Health Effects of Cannabis, Addiction Research Foundation, Division of the, Ontario, Canada, pp. 71 - 125
,1999, 'Heroin and other opioid overdose deaths in Australia', in Heroin crisis, Bookman Press, Melbourne, Victoria, Australia, pp. 170 - 176
,1999, 'Introduction [The Health Effects of Cannabis]', in The Health Effects of Cannabis, Addiction Research Foundation, Division of the, Ontario, Canada, pp. 9 - 11
,1999, 'Mental and behavioral disorders due to cannabis use', in The Health Effects of Cannabis, Addiction Research Foundation, Division of the, Ontario, Canada, pp. 269 - 290
,1998, 'Assessment for opioid replacement therapy', in Methadone Maintenance Treatment and Other Opioid Replacement Therapies, Harwood Academic Publishers, The Netherlands, pp. 177 - 203
,1998, 'How long is long enough? Answers to questions about the duration of methadone maintenance treatment', in Methadone Maintenance Treatment and Other Opioid Replacement Therapies, Harwood Academic Publishers, The Netherlands, pp. 305 - 336
,1998, 'Introduction [Methadone Maintenance Treatment and Other Opioid Replacement Therapies]', in Methadone Maintenance Treatment and Other Opioid Replacement Therapies, Harwood Academic Publishers, The Netherlands, pp. 1 - 14
,1998, 'Making the transition from maintenance to abstinence: Detoxification from methadone maintenance treatment', in Methadone Maintenance Treatment and Other Opioid Replacement Therapies, Harwood Academic Publishers, The Netherlands, pp. 337 - 358
,1998, 'Methadone maintenance during pregnancy', in Methadone Maintenance Treatment and Other Opioid Replacement Therapies, Harwood Academic Publishers, The Netherlands, pp. 397 - 417
,1998, 'Psychiatric comorbidity among the opioid dependent', in Methadone Maintenance Treatment and Other Opioid Replacement Therapies, Harwood Academic Publishers, The Netherlands, pp. 419 - 440
,1998, 'The effectiveness of methadone maintenance treatment 1:heroin use and crime', in Methadone Maintenance Treatment and Other Opioid Replacement Therapies, Harwood Academic Publishers, The Netherlands, pp. 17 - 57
,1998, 'The effectiveness of methadone maintenance treatment 2:HIV and infectious hepatitis', in Methadone Maintenance Treatment and Other Opioid Replacement Therapies, Harwood Academic Publishers, The Netherlands, pp. 59 - 73
,1998, 'The effectiveness of other opioid replacement therapies: LAAM, heroin, buprenorphine, naltrexone and injectable maintenance', in Methadone Maintenance Treatment and Other Opioid Replacement Therapies, Harwood Academic Publishers, The Netherlands, pp. 123 - 157
,1998, 'The future of opioid replacement therapy', in Methadone Maintenance Treatment and Other Opioid Replacement Therapies, Harwood Academic Publishers, The Netherlands, pp. 443 - 471
,1998, 'The provision of methadone within prison settings', in Methadone Maintenance Treatment and Other Opioid Replacement Therapies, Harwood Academic Publishers, The Netherlands, pp. 379 - 396
,1998, 'The role of counselling and psychological therapy', in Methadone Maintenance Treatment and Other Opioid Replacement Therapies, Harwood Academic Publishers, The Netherlands, pp. 265 - 304
,1998, 'The use of methadone during maintenance treatment: Pharmacology, dosage and treatment outcome', in Methadone Maintenance Treatment and Other Opioid Replacement Therapies, Harwood Academic Publishers, The Netherlands, pp. 205 - 238
,1998, 'The use of urinalysis during opioid replacement therapy', in Methadone Maintenance Treatment and Other Opioid Replacement Therapies, Harwood Academic Publishers, The Netherlands, pp. 239 - 264
,1997, 'Patterns of amphetamine misuse in Australia', in Amphetamine Misuse: International perspectives on current trends, Harwood Academic Publishers, Reading, pp. 81 - 110
,1996, 'Benzodiazepine injecting among heroin users', in Topp L; Dillon P (ed.), Looking to the future: A second generation of drug research. Proceedings from the Tenth National Drug and Alcohol Research Centre Annual Symposium, National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW, Australia
,1995, 'Australia', in International Heandbook on Alcohol and Culture, Greenwood Press, London, pp. 7 - 75
,2023, E-Cigarettes and the Comparative Politics of Harm Reduction: History, Evidence, and Policy, http://dx.doi.org/10.1007/978-3-031-23658-7
,